Zobrazeno 1 - 10
of 43
pro vyhledávání: '"P R, Kowey"'
Autor:
Brian Olshansky, Deepak L. Bhatt, Michael Miller, Ph. Gabriel Steg, Eliot A. Brinton, Terry A. Jacobson, Steven B. Ketchum, Ralph T. Doyle, Rebecca A. Juliano, Lixia Jiao, Peter R. Kowey, James A. Reiffel, Jean‐Claude Tardif, Christie M. Ballantyne, Mina K. Chung
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 5 (2023)
Background In REDUCE‐IT (Reduction of Cardiovascular Events With Icosapent Ethyl–Intervention Trial), icosapent ethyl (IPE) versus placebo) reduced cardiovascular death, myocardial infarction, stroke, coronary revascularization, or unstable angin
Externí odkaz:
https://doaj.org/article/50b39d01ac344246a098267d5fb32c73
Autor:
A. John Camm, Carina Blomström‐Lundqvist, Giuseppe Boriani, Andreas Goette, Peter R. Kowey, Jose L. Merino, Jonathan P. Piccini, Sanjeev Saksena, James A. Reiffel
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 6 (2022)
Background Guideline recommendations are the accepted reference for selection of therapies for rhythm control of atrial fibrillation (AF). This study was designed to understand physicians’ treatment practices and adherence to guidelines. Methods an
Externí odkaz:
https://doaj.org/article/2cb60d2d2cca49dfa6a1ee2878ef6802
Autor:
Steven H Back, Peter R Kowey
Publikováno v:
Arrhythmia & Electrophysiology Review, Vol 8, Iss 2, Pp 99-104 (2019)
Externí odkaz:
https://doaj.org/article/f7023777455f46b8944f60a698ada91e
Autor:
Alexander C. Perino, Peter Shrader, Mintu P. Turakhia, Jack E. Ansell, Bernard J. Gersh, Gregg C. Fonarow, Alan S. Go, Daniel W. Kaiser, Elaine M. Hylek, Peter R. Kowey, Daniel E. Singer, Laine Thomas, Benjamin A. Steinberg, Eric D. Peterson, Jonathan P. Piccini, Kenneth W. Mahaffey
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 8, Iss 9 (2019)
Background Patient satisfaction with therapy is an important metric of care quality and has been associated with greater medication persistence. We evaluated the association of patient satisfaction with warfarin therapy to other metrics of anticoagul
Externí odkaz:
https://doaj.org/article/3f5c0c4632c64617860042a4d7d61964
Autor:
Jeffrey B. Washam, DaJuanicia N. Holmes, Laine E. Thomas, Sean D. Pokorney, Elaine M. Hylek, Gregg C. Fonarow, Kenneth W. Mahaffey, Bernard J. Gersh, Peter R. Kowey, Jack E. Ansell, Alan S. Go, James A. Reiffel, James V. Freeman, Daniel E. Singer, Gerald Naccarelli, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 18 (2018)
Background Chronic kidney disease (CKD) is a common comorbidity in patients with atrial fibrillation. The presence of CKD complicates drug selection for stroke prevention and rhythm control. Methods and Results Patients enrolled in ORBIT AF (Outcomes
Externí odkaz:
https://doaj.org/article/0ef1abfb713f46d0b6b200b18ab7877d
Autor:
Larry R. Jackson, Sunghee Kim, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Alan S. Go, Elaine M. Hylek, Peter R. Kowey, Kenneth W. Mahaffey, Daniel Singer, Laine Thomas, Rosalia Blanco, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 16 (2018)
Background Current American College of Cardiology/American Heart Association guidelines suggest that for patients with atrial fibrillation who are at low risk for stroke (CHA2DS2VASc=1) (or women with CHA2DS2VASc=2) a variety of treatment strategies
Externí odkaz:
https://doaj.org/article/8ce4f7b0b1244941b72910ec3023eed1
Autor:
Emily C. O'Brien, DaJuanicia N. Holmes, Laine Thomas, Gregg C. Fonarow, Peter R. Kowey, Jack E. Ansell, Kenneth W. Mahaffey, Bernard J. Gersh, Eric D. Peterson, Jonathan P. Piccini, Elaine M. Hylek
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 12 (2018)
Background Oral anticoagulation (OAC) reduces stroke risk in atrial fibrillation, but bleeding is a frequent side effect. The decision to discontinue or modify medication regimens in response to a bleeding event may differ according to bleeding site
Externí odkaz:
https://doaj.org/article/5acfc9bb443040bcb5602ad56fff1b24
Autor:
Marat Fudim, Peter R. Liu, Peter Shrader, Rosalia G. Blanco, Larry A. Allen, Gregg C. Fonarow, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Elaine Hylek, Alan S. Go, Laine Thomas, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 8 (2018)
BackgroundMineralocorticoid receptor antagonist (MRA) therapy may be beneficial to patients with atrial fibrillation (AF), but little is known about their use in patients with AF and subsequent outcomes. Methods and ResultsIn order to better understa
Externí odkaz:
https://doaj.org/article/eb51a26d0f394ca0bdfc303ffb378af9
Autor:
Benjamin A. Steinberg, Peter Shrader, Karen Pieper, Laine Thomas, Larry A. Allen, Jack Ansell, Paul S. Chan, Michael D. Ezekowitz, Gregg C. Fonarow, James V. Freeman, Bernard J. Gersh, Peter R. Kowey, Kenneth W. Mahaffey, Gerald V. Naccarelli, James A. Reiffel, Daniel E. Singer, Eric D. Peterson, Jonathan P. Piccini
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 4 (2018)
BackgroundNon–vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in certain patients. We sought to describe the frequency, appropriateness (according to Food and
Externí odkaz:
https://doaj.org/article/94065e7f773f4491acdd52f9639b13ed
Autor:
B Kreidieh, J P Singh, C Blomstrom-Lundqvist, M P Turakhia, A J Camm, M S Fazeli, C Crotty, P R Kowey
Publikováno v:
European Heart Journal. 43
Background There are limited comparative data on safety and efficacy within Vaughn Williams class III anti-arrhythmic drugs (AADs) for maintenance of sinus rhythm in adults with atrial fibrillation (AF). Purpose We sought to compare the safety and ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51833dc2fb0026f249af298209564ab4
https://doi.org/10.1093/eurheartj/ehac544.574
https://doi.org/10.1093/eurheartj/ehac544.574